Adage Capital Partners Gp, L.L.C. Imago Bio Sciences, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $375,750 - $899,000	25,000 Added 12.5%	225,000 $8.09 Million
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $353,750 - $487,500	-25,000 Reduced 11.11%	200,000 $3.01 Million
Q2 2022 Aug 15, 2022	SELL	$11.81 - $20.92 $590,500 - $1.05 Million	-50,000 Reduced 18.18%	225,000 $3.01 Million
Q4 2021 Feb 14, 2022	SELL	$16.22 - $29.69 $1.94 Million - $3.55 Million	-119,586 Reduced 30.31%	275,000 $6.52 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $6.31 Million - $11.4 Million	394,586 New	394,586 $7.9 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.